Go to deals
Healthcare

Open Orphan has successfully raised capital in an oversubscribed fundraise

Open Orphan Plc has completed an equity placing to raise US$15.5 million to maximize available COVID-19 opportunities and testing.

Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Open Orphan comprises of two commercial specialist CRO services businesses: hVIVO and Venn Life Sciences, and has offices in London, Dublin, Paris and the Netherlands. The company is led by a management team with deep industry and financial experience.

Oaklins Cavendish’s sister firm finnCap, based in the UK, advised Open Orphan Plc on its oversubscribed equity fundraising of US$15.5 million.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Geoff  Nash

Geoff Nash

Partner

London, United Kingdom
Oaklins Cavendish

Related deals

Dutch Star Companies TWO succesfully lists in a US$130 million IPO
Financial Services

Dutch Star Companies TWO succesfully lists in a US$130 million IPO

Dutch Star Companies TWO (DSC2), powered by Oaklins Netherlands, has raised US$130 million and has successfully listed on Euronext Amsterdam with the aim of forming a business combination with a Dutch mid-sized target company.

Learn more
Spring has completed an equity raise
Real Estate

Spring has completed an equity raise

The owners and management of Spring have completed a fundraising to support its growth strategy.

Learn more
CML Group (ASX:CGR) has completed a placement
Financial Services

CML Group (ASX:CGR) has completed a placement

CML Group (ASX:CGR) has completed a US$2.5 million placement. The raise was completed at an issue price of US$0.238 (A$0.328) per share to institutional and professional investors. Funds raised will be used to support the company’s cash position to fund growth in its loan book.

Learn more